轩竹生物科技股份有限公司（“轩竹生物-B”）于2026年8月6日披露截至2026年7月31日的股份变动月报。公告显示，公司注册股本（已发行股本）在本月保持不变。
根据公告，轩竹生物科技股份有限公司于本月无新增发行、股份回购、注销或库藏股等变动。普通股（H股）截至7月底的已发行股份总数仍为517,947,790股，与上月底的517,947,790股保持一致。公司确认已经满足适用的公众持股量要求，公告披露其上市时所规定的H股公众持股量门槛为24.96%。
此外，公告显示本月无涉及股份期权、股权激励计划、可转换债券或其他与股本发行相关的安排。公司表示，截至2026年7月末，股本情况总体稳定，注册股本总额为人民币517,947,790元。
公告由公司联席公司秘书何成明签署。公司强调将继续严格遵守香港联交所《上市规则》及相关法律法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.